Plan B Decision Made Before Data Review

WASHINGTON, Aug 3 (Reuters) - The decision whether the U.S. Food and Drug Administration should approve wider access to a morning-after contraceptive drug was made well before agency scientists finished their final review, two FDA officials said in court documents released on Thursday.

>>> Discuss This Story

Back to news